Middle East & Africa Transfection Reagents and Equipment Market
No. of Pages: 108 | Report Code: BMIRE00030478 | Category: Life Sciences
No. of Pages: 108 | Report Code: BMIRE00030478 | Category: Life Sciences
The Middle East & Africa transfection reagents and equipment market was valued at US$ 46.15 million in 2022 and is expected to reach US$ 80.53 million by 2030; it is estimated to register at a CAGR of 7.2% from 2022 to 2030. Increasing Popularity of Cell and Gene Therapy Bolsters Middle East & Africa Transfection Reagents and Equipment Market
Cell and gene therapy manufacturing is a complicated process, which makes its execution and monitoring critical. Advancements in biotechnology have led to the adoption of personalized treatments for the treatment of numerous indications. Cell and gene therapies mostly are used to treat chronic diseases such as neurological disorders, cancer, and genetic disorders. The noteworthy advantages of cell and gene therapy include targeted treatment, faster and more efficient recovery, and reduced side effects. Cell and gene therapies are widely adopted across the world owing to the availability of Food and Drug Administration (FDA) approved products. For instance, the FDA approved an adenovirus ADSTILADRIN manufactured by Ferring Pharmaceuticals A/S in 2022. This recombinant adenovirus (rAd-IFNa/Syn3) delivers human interferon alfa-2b cDNA into the bladder epithelium to treat patients suffering from certain types of bladder cancer. In 2022, CARVYKTI, manufactured by Janssen Biotech, Inc., was also approved by the FDA. CARVYKTI is an autologous CAR-T cell engineered with lentivirus to attack BCMA-expressing tumor cells for the treatment of certain kinds of relapsed or refractory multiple myeloma. Scientists are nowadays employing the transfection technique for the production of these therapies. Hence, an upsurge in the popularity of cell and gene therapy activities fuels the number of transfection procedures performed, which, in turn, fuels the growth of the Middle East & Africa transfection reagents and equipment market.Middle East & Africa Transfection Reagents and Equipment Market Overview
Middle East and Africa region is classified into Saudi Arabia, South Africa, United Arab Emirates, and Rest of Middle East and Africa. Saudi Arabia hold the largest market share in the year 2022.
The growth of the pharmaceutical industry in Middle East and Africa is widely driven by investments made by multinational pharmaceutical companies in countries such as Saudi Arabia, South Africa, United Arab Emirates, and more. In January 2023, Saudi Arabia's Ministry of Investment signed two memorandums of understanding to improve joint cooperation with the biotechnology and medicine industries in the kingdom. The ministry signed one agreement with Boehringer Ingelheim, a German company, for the enhancement of the pharmaceutical industry. The second MoU was signed with Novo Nordisk Saudi Arabia and King Abdullah University of Science and Technology with an aim to contribute to providing solutions for developing community awareness about the concepts of metabolic disorders, obesity, and diabetes. Such efforts made to make people aware of rare and chronic medical conditions are likely to bolster the transfection reagents and equipment market in Saudi Arabia in the coming years.
Furthermore, partnerships between companies in these countries propelling the market growth, in December 2021, Secondcell Bio and Alliance Care Technologies International announced a new strategic partnership for establishing a novel, cutting-edge research facility focused on cell therapy and rapid drug discovery for combating rare genetic diseases in the UAE. The Chromovert technology is far ahead of CRISPR, and it has extensive potential to streamline the drug discovery process by enabling the generation of cells that were previously designed for improved drug discovery.
Middle East & Africa Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)
Strategic insights for the Middle East & Africa Transfection Reagents and Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the Middle East & Africa Transfection Reagents and Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
Get more information on this report Middle East & Africa Transfection Reagents and Equipment Strategic Insights
Get more information on this report Middle East & Africa Transfection Reagents and Equipment Report Scope
Report Attribute
Details
Market size in 2022
US$ 46.15 Million
Market Size by 2030
US$ 80.53 Million
Global CAGR (2022 - 2030)
7.2%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product
By Method
By End User
Regions and Countries Covered
Middle East and Africa
Market leaders and key company profiles
Get more information on this report Middle East & Africa Transfection Reagents and Equipment Regional Insights
Get more information on this report
Middle East & Africa Transfection Reagents and Equipment Market Segmentation
The Middle East & Africa transfection reagents and equipment market is segmented based on product, method, application, end user, and country.
Based on product, the Middle East & Africa transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.
In terms of method, the Middle East & Africa transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.
By application, the Middle East & Africa transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.
Based on end user, the Middle East & Africa transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.
Based on country, the Middle East & Africa transfection reagents and equipment market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa transfection reagents and equipment market in 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the Middle East & Africa transfection reagents and equipment market.
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
The Middle East & Africa Transfection Reagents and Equipment Market is valued at US$ 46.15 Million in 2022, it is projected to reach US$ 80.53 Million by 2030.
As per our report Middle East & Africa Transfection Reagents and Equipment Market, the market size is valued at US$ 46.15 Million in 2022, projecting it to reach US$ 80.53 Million by 2030. This translates to a CAGR of approximately 7.2% during the forecast period.
The Middle East & Africa Transfection Reagents and Equipment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Transfection Reagents and Equipment Market report:
The Middle East & Africa Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Transfection Reagents and Equipment Market
